FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Medtronics MiniMed 780G Gets FDA Approval

After a delay caused by an FDA 2021 inspection and Warning Letter, the agency approves Medtronics MiniMed 780G insulin pump.

latest-news-card-1
Biologics

bluebird bio BLA for Sickle Cell Gene Therapy

bluebird bio files for priority review a BLA for lovotibeglogene autotemcel (lovo-cel), a gene therapy for patients with sickle cell disease.

latest-news-card-1
Human Drugs

Generic Group Questions Guide on Guidance Meetings

Generic drug lobbying arm says FDAs draft guidance entitled Product-Specific Guidance (PSG) Meetings Between FDA and ANDA Applicants Under GDUFA does ...

latest-news-card-1
Human Drugs

Foghorn Therapeutics Hit with Partial Clinical Hold

FDA places a partial clinical hold on a Foghorn Therapeutics clinical study of FHD-609 in synovial sarcoma and SMARCB1-deleted tumors after the compan...

Medical Devices

FDA Clear Maxtecs Oxygen Monitor

FDA clears a Maxtec 510(k) for the MaxO2 ME+p, an oxygen monitor with integrated pressure monitoring intended for continuous patient monitoring.

latest-news-card-1
Medical Devices

Avanos Medical Recalls Respiratory Suction Device

Avanos Medical recalls its Avanos Ballard Access Closed Suction System with Y-Manifold or Elbow Manifold after receiving complaints about cracked mani...

latest-news-card-1
Human Drugs

FDA Extends Review of Daiichi Leukemia NDA

FDA extends by three months its review of a Daiichi Sankyo NDA resubmisson for quizartinib in combination with chemotherapy for treating adult patien...

latest-news-card-1
Human Drugs

CDER Denies Bausch Petition on Duobrii ANDAs

CDER denies a 2021 citizen petition from Bausch Health that urged FDA not to approve any ANDA that cites Duobrii as the reference-listed drug unless t...

latest-news-card-1
Human Drugs

Novartis Gets Another Facility OKd for Pluvicto

FDA approves Novartis Radioligand Therapy manufacturing facility in Millburn, NJ to manufacture prostate cancer therapy Pluvicto, which has been in sh...

latest-news-card-1
Human Drugs

DTC Research Raises Concern on Endpoints in Cancer Ads

New research on drug direct-to-consumer television advertising finds that viewers misinterpreted certain oncology clinical trial endpoint-related clai...